Induction of Hantaan virus-specific immune responses in C57BL/6 mice by immunization with a modified recombinant adenovirus containing the chimeric gene, GcS0.7

International Journal of Molecular Medicine

Volumn 32, Issue 3, 2013, Pages 709-716

  Li, Kai ^a   Li, Pu Yuan ^a   Wu, Xing An ^a   Zhang, Liang ^a   Liu, Zi Yu ^a   Yu, Lan ^a   Zhang, Lei ^a   Cheng, Lin Feng ^a   Bai, Wen Tao ^b   Zhang, Fang Lin ^a   Xu, Zhi Kai ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Chimeric gene; Hantaan virus

Indexed keywords

ADENOVIRUS VECTOR; BETA ACTIN; GAMMA INTERFERON; HANTAVIRUS GLYCOPROTEIN GCS0.7 VACCINE; INACTIVATED VACCINE; NUCLEOCAPSID PROTEIN; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; DRUG EFFICACY; HANTAVIRUS INFECTION; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INFECTION RESISTANCE; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WOODCHUCK HEPATITIS VIRUS;

ADENOVIRIDAE; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CELL LINE; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; GENE ORDER; GENETIC VECTORS; HANTAAN VIRUS; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; MICE; RECOMBINANT FUSION PROTEINS; VIRAL PROTEINS; VIRAL VACCINES;

EID: 84880424640     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1421     Document Type: Article

References (31)

1. Hepojoki J, Strandin T, Lankinen H and Vaheri A: Hantavirus structure - molecular interactions behind the scene. J Gen Virol 93: 1631-1644, 2012.
2. Plyusnin A, Vapalahti O and Vaheri A: Hantaviruses: genome structure, expression and evolution. J Gen Virol 77: 2677-2687, 1996.
3. Charrel RN, Coutard B, Baronti C, et al: Arenaviruses and hantaviruses: from epidemiology and genomics to antivirals. Antiviral Res 90: 102-114, 2011.
4. Hart CA and Bennett M: Hantavirus infections: epidemiology and pathogenesis. Microbes Infect 1: 1229-1237, 1999.
5. Clement JP: Hantavirus. Antiviral Res 57: 121-127, 2003.
6. Kruger DH, Schonrich G and Klempa B: Human pathogenic hantaviruses and prevention of infection. Hum Vaccin 7: 685-693, 2011.
7. Simmons JH and Riley LK: Hantaviruses: an overview. Comp Med 52: 97-110, 2002.
8. Kariwa H, Yoshimatsu K and Arikawa J: Hantavirus infection in East Asia. Comp Immunol Microbiol Infect Dis 30: 341-356, 2007.
9. Schmaljohn C: Vaccines for hantaviruses. Vaccine 27 (Suppl 4): D61-D64, 2009.
10. Khaiboullina SF and St Jeor SC: Hantavirus immunology. Viral Immunol 15: 609-625, 2002.
11. Van Epps HL, Schmaljohn CS and Ennis FA: Human memory cytotoxic T-lymphocyte (CTL) responses to Hantaan virus infection: identification of virus-specific and cross-reactive CD8(+) CTL epitopes on nucleocapsid protein. J Virol 73: 5301-5308, 1999.
12. Yoshimatsu K, Yoo YC, Yoshida R, Ishihara C, Azuma I and Arikawa J: Protective immunity of Hantaan virus nucleocapsid and envelope protein studied using baculovirus-expressed proteins. Arch Virol 130: 365-376, 1993.
13. Xue X, Xu Z and Ma W: Expression of truncated HTNV nucleoprotein and analysis of antigenic epitope. Virol Sin 15: 220-225, 2000.
14. Zhang FL, Wu XA, Luo W, et al: The expression and genetic immunization of chimeric fragment of Hantaan virus M and S segments. Biochem Biophys Res Commun 354: 858-863, 2007.
15. Luo W, Zhang F, Yan Y, et al: Immunological properties of a fusion protein containing nucleocapsid protein and glycoprotein Gn of Hantaan virus. Acta Virol 52: 243-249, 2008.
16. Gribaudo G, Ravaglia S, Caliendo A, et al: Interferons inhibit onset of murine cytomegalovirus immediate-early gene transcription. Virology 197: 303-311, 1993.
17. Donello JE, Loeb JE and Hope TJ: Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element. J Virol 72: 5085-5092, 1998.
18. Real G, Monteiro F, Burger C and Alves PM: Improvement of lentiviral transfer vectors using cis-acting regulatory elements for increased gene expression. Appl Microbiol Biotechnol 91: 1581-1591, 2011.
19. Xu ZL, Mizuguchi H, Mayumi T and Hayakawa T: Woodchuck hepatitis virus post-transcriptional regulation element enhances transgene expression from adenovirus vectors. Biochim Biophys Acta 1621: 266-271, 2003.
20. Zufferey R, Donello JE, Trono D and Hope TJ: Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 73: 2886-2892, 1999.
21. Garg S, Oran AE, Hon H and Jacob J: The hybrid cytomegalovirus enhancer/chicken beta-actin promoter along with woodchuck hepatitis virus posttranscriptional regulatory element enhances the protective efficacy of DNA vaccines. J Immunol 173: 550-558, 2004.
22. Li PY, Yu L, Wu XA, et al: Modification of the adenoviral transfer vector enhances expression of the Hantavirus fusion protein GnS0.7 and induces a strong immune response in C57BL/6 mice. J Virol Methods 179: 90-96, 2012.
23. Xu Z, Wei L, Wang L, Wang H and Jiang S: The in vitro and in vivo protective activity of monoclonal antibodies directed against Hantaan virus: potential application for immunotherapy and passive immunization. Biochem Biophys Res Commun 298: 552-558, 2002.
24. Zhang F, Liu Y, Yu L, et al: Construction and identification of recombinant adenovirus containing chimeric gene G2S0.7 of Hantaan virus. J Fourth Mil Med Univ 25: 1057-1060, 2004.
25. Kruger DH, Ulrich R and Lundkvist AA: Hantavirus infections and their prevention. Microbes Infect 3: 1129-1144, 2001.
26. Hooper JW and Li D: Vaccines against hantaviruses. Curr Top Microbiol Immunol 256: 171-191, 2001.
27. Schonrich G, Rang A, Lutteke N, Raftery MJ, Charbonnel N and Ulrich RG: Hantavirus-induced immunity in rodent reservoirs and humans. Immunol Rev 225: 163-189, 2008.
28. Tischler ND, Gonzalez A, Perez-Acle T, Rosemblatt M and Valenzuela PD: Hantavirus Gc glycoprotein: evidence for a class II fusion protein. J Gen Virol 86: 2937-2947, 2005.
29. Klein R, Ruttkowski B, Knapp E, Salmons B, Gunzburg WH and Hohenadl C: WPRE-mediated enhancement of gene expression is promoter and cell line specific. Gene 372: 153-161, 2006.
30. Richardson JS, Yao MK, Tran KN, et al: Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccine. PLoS One 4: e5308, 2009.
31. Lehmann PV and Zhang W: Unique strengths of ELISPOT for T cell diagnostics. Methods Mol Biol 792: 3-23, 2012.